NNH-52489-65990
3 vaccinations
2 coded responses
29 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 752 / TX
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2021-01-04
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-31
- 2021-02-21
- 2021-04-09
-
2021-11-23
Dose 3 — Pfizer-BioNTech
-
2021-11-23
Survey response — day 0, dose 3MedDRA: Pregnancy — Feeling: Good · Fatigue or tiredness, NauseaFree text: I am pregnantMedDRA releases: 2024-11 · check-in free text available
-
2021-11-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-11-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, NauseaAdult check-in
-
2021-11-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Muscle or body aches, NauseaAdult check-in
- 2021-11-27
- 2021-11-28
- 2021-11-29
-
2021-11-30
Health check-in — day 7, dose 3Feeling: Good · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-12-09
- 2021-12-14
-
2021-12-23
Survey response — day 28, dose 3MedDRA: Chills, Cough, Fatigue, Headache, Occupational exposure to SARS-CoV-2, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 12/15 high risk Covid exposure at work, 12/18: fever, cough, sore throat, headache, fatigue chills. 12/19: sore throat headache, no fever. 12/20-12/23 cough and headache no fever. Covid pcr test negative 12/18, 12/19 and 12/22MedDRA releases: 2024-11 · check-in free text available
- 2021-12-28
- 2022-01-04
- 2022-02-22
- 2022-05-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 priority 2/3 (triaged and no follow up)
Free text
Release 10 — day 0, dose 3
Systemic reaction (other): I am pregnant
Release 10 — day 28, dose 3
Symptoms: 12/15 high risk Covid exposure at work, 12/18: fever, cough, sore throat, headache, fatigue chills. 12/19: sore throat headache, no fever. 12/20-12/23 cough and headache no fever. Covid pcr test negative 12/18, 12/19 and 12/22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Occupational exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release